Characteristics of Immunoglobulin M Type Antibodies of Different Origins from the Immunologic and Clinical Viewpoints and Their Application in Controlling Antibody-Mediated Allograft Rejection

Characteristics of Immunoglobulin M Type Antibodies of Different Origins from the Immunologic and Clinical Viewpoints and Their Application in Controlling Antibody-Mediated Allograft Rejection

Antibody-mediated allograft rejection (AMR) hinders patient prognosis after organ transplantation. Current studies concerning AMR have mainly focused on the diagnostic value of immunoglobulin G (IgG)-type donor-specific antihuman leukocyte antigen antibodies (DSAs), primarily because of their antige...

Full description

Bibliographic Details
Main Authors:	Yoshiko Matsuda, Takahisa Hiramitsu, Xiao-kang Li, Takeshi Watanabe
Format:	Article
Language:	English
Published:	MDPI AG 2020-12-01
Series:	Pathogens
Subjects:	Antibody-mediated allograft rejection (AMR) donor-specific antihuman leukocyte antigen antibodies (DSAs) IgM antibodies innate B cell conventional B cell
Online Access:	https://www.mdpi.com/2076-0817/10/1/4

Similar Items

Approaches for Controlling Antibody-Mediated Allograft Rejection Through Targeting B Cells
by: Yoshiko Matsuda, et al.
Published: (2021-07-01)

Impact of Immunoglobulin M-Type Donor-Specific Human Leukocyte Antigen–Antibody Levels in Supernatants from Cultured Peripheral Blood Mononuclear Cells as Predictors of Antibody-Mediated Rejection
by: Ryoichi Imamura, et al.
Published: (2020-09-01)

Contribution of long-lived plasma cells to antibody-mediated allograft rejection
by: Eunkyeong Jang, et al.
Published: (2024-12-01)

Extracellular vesicles: a potential new player in antibody-mediated rejection in lung allograft recipients
by: Sandhya Bansal, et al.
Published: (2023-09-01)

ACCELERATED HUMORAL (ANTIBODY-MEDIATED) REJECTION OF THE CARDIAC ALLOGRAFT (A CASE REPORT)
by: A. G. Kupriyanova, et al.
Published: (2011-06-01)

Treatment of donor‐specific antibody‐mediated rejection after heart transplantation by IgM‐enriched human immunoglobulin
by: Moritz Benjamin Immohr, et al.
Published: (2021-08-01)

Immunopathology of Corneal Allograft Rejection and Donor-Specific Antibodies (DSAs) as Immunological Predictors of Corneal Transplant Failure
by: Natalia Olejkowska, et al.
Published: (2024-09-01)

Allograft rejection in kidney transplantation – A retrospective study of impact on graft and patient outcome
by: M P Shamsudheen, et al.
Published: (2022-01-01)

Allo-Specific Humoral Responses: New Methods for Screening Donor-Specific Antibody and Characterization of HLA-Specific Memory B Cells
by: Shengli Song, et al.
Published: (2021-07-01)

Time-dependent blood eosinophilia count increases the risk of kidney allograft rejection
by: Luc Colas, MD, PhD, et al.
Published: (2021-11-01)

Prevalence and risk factors of antibodies towards HLA Class I and Class II in Malaysian renal transplant candidates
by: Norfarhana Khairul-Fahmy, et al.
Published: (2023-02-01)

Serum Soluble B Cell-Activating Factor Is a Non-Invasive Biomarker of Antibody-Mediated Rejection in Kidney Allograft With Satisfactory Risk Stratification Performance But Negligible Diagnostic Value
by: Shenghui Wu, et al.
Published: (2022-04-01)

Unravelling the role of allo-antibodies and Transplant Injury
by: Yoshiko Matsuda, et al.
Published: (2016-10-01)

Clinical significance of donor-specific anti-HLA-DR51/52/53 antibodies for antibody-mediated rejection in kidney transplant recipients
by: Borae Geum Park, et al.
Published: (2019-09-01)

Immune Cell Infiltrate in Chronic-Active Antibody-Mediated Rejection
by: Kasia A. Sablik, et al.
Published: (2020-02-01)

Anti-complement 5 antibody ameliorates antibody-mediated rejection after liver transplantation in rats
by: Tetsuya Tajima, et al.
Published: (2023-06-01)

Gender aspects of incidence of antibody-mediated rejection and allograft vasculopathy events after heart transplantation
by: N. N. Koloskova, et al.
Published: (2019-05-01)

The Summarized Assessment of Endothelin A Receptor Expression in Renal Transplant Compartments Associated with Antibody-Mediated Rejection
by: Mirosław Banasik, et al.
Published: (2021-12-01)

An Antibody-Aptamer-Hybrid Lateral Flow Assay for Detection of CXCL9 in Antibody-Mediated Rejection after Kidney Transplantation
by: Lisa K. Seiler, et al.
Published: (2022-01-01)

Antibody-mediated Rejection in Kidney Transplant: An Unmastered Area
by: Shahul Valavoor, et al.
Published: (2024-06-01)

The impact of HLA class I-specific killer cell immunoglobulin-like receptors on antibody-dependent natural killer cell-mediated cytotoxicity and organ allograft rejection
by: Raja Rajalingam
Published: (2016-12-01)

Impact of Transient and Persistent Donor-Specific Antibodies in Lung Transplantation
by: S. Auner, et al.
Published: (2024-05-01)

Antigen–antibody complex density and antibody-induced HLA protein unfolding influence Fc-mediated antibody effector function
by: Tanusya Murali Murali, et al.
Published: (2024-12-01)

COMPARISON OF DIFFERENT METHODS OF ANTI-HLA ANTIBODIES DETECTION IN DIAGNOSIS OF ANTIBODY-MEDIATED RENAL ALLOGRAFT REJECTION
by: E. S. Ivanova, et al.
Published: (2016-11-01)

Non-Invasive Biomarkers for Early Diagnosis of Kidney Allograft Dysfunction: Current and Future Applications in the Era of Precision Medicine
by: Christina Lazarou, et al.
Published: (2025-02-01)

THE EXPERIENCE OF IMMUNOHISTOCHEMICAL INVESTIGATION OF ENDOMIOCARDIAL BIOPSIES FOR THE DIAGNOSIS OF THE HUMORAL REJECTION IN THE PATIENTS WITH HEART ALLOGRAFT
by: A. G. Kupriyanova, et al.
Published: (2009-05-01)

Challenges and opportunities for designing clinical trials for antibody mediated rejection
by: Suryanarayanan Balakrishnan, et al.
Published: (2024-06-01)

INTRAVENOUS IMMUNOGLOBULIN ADMINISTRATION FOR DESENSITIZATION BEFORE RENAL TRANSPLANTATION AND MANAGING ANTIBODY-MEDIATED REJECTION
by: A. I. Sushkov, et al.
Published: (2011-06-01)

The Role of the Endothelium during Antibody-Mediated Rejection: From Victim to Accomplice
by: Amy Rachael Cross, et al.
Published: (2018-01-01)

Specialized Roles of Human Natural Killer Cell Subsets in Kidney Transplant Rejection
by: Katrina Kildey, et al.
Published: (2019-08-01)

Treatment of Antibody-Mediated Rejection in Kidney Transplantation
by: Magdalena Durlik
Published: (2013-07-01)

Disruption of Tfh:B Cell Interactions Prevents Antibody-Mediated Rejection in a Kidney Transplant Model in Rats: Impact of Calcineurin Inhibitor Dose
by: Louisa Steines, et al.
Published: (2021-05-01)

Chronic Renal Allograft Dysfunction Antibody-Mediated: An Update
by: Maurizio Salvadori,, et al.
Published: (2014-07-01)

Efficacy and safety of bortezomib in the treatment of active antibody-mediated rejection in adult kidney-transplant recipients: A single-center retrospective study
by: Dharmendra Bhadauria, et al.
Published: (2022-01-01)

Renal allograft rejection, lymphocyte infiltration, and de novo donor-specific antibodies in a novel model of non-adherence to immunosuppressive therapy
by: Louisa Kühne, et al.
Published: (2017-12-01)

Vascular rejection in cardiac allograft vasculopathy: Impact on graft survival
by: Nandini Nair
Published: (2022-08-01)

Histopathologic Features of Antibody Mediated Rejection: The Banff Classification and Beyond
by: Lynn D. Cornell
Published: (2021-09-01)

Successful treatment of acute antibody-mediated rejection of liver allograft with imlifidase: A case report
by: Michie A. Adjei, et al.
Published: (2023-09-01)

Evaluation of Anti- HLA Class I Antibodies in Chronic Rejection of Kidney Transplantation
by: "Mohammad Hossein Nicknam, et al.
Published: (2004-06-01)

Human B-1 Cells and B-1 Cell Antibodies Change With Advancing Age
by: Nely Rodriguez-Zhurbenko, et al.
Published: (2019-03-01)